![[D] CustoMem changes name to Puraffinity, secures new funds](/uploads/r/null/e/9/5/e95a51873b7a3dc582de3f84a707b10e498acc41ae289c7b10ed1e5183f63ff0/b560cd31-2e06-4483-a0da-77493d4ba728-_D__screencapture-wwtonline-co-uk-news-customem-changes-name-to-puraffinity-secures-new-funds-2021-03-02-09_22_58_142.jpg)
Item
·
31/7/2019
Part of UoA 8
Puraffinity securing new funds
![[D] Combined evidence of impact within France](/uploads/r/null/e/a/0/ea05b73e27472767e01a297efb580248dd37e25ff8c300cefefb8e993ee597d3/6bd74d97-ad37-40a6-aefb-45b1872f8480-_D__Impact_in_France_142.jpg)
![[D] Carrick Therapeutics Press announces first patient on CT7001 30th Nov 2017.pdf](/uploads/r/null/f/f/d/ffda5c3a4f4c68f44f65e474e112a266e2803f92ccf4b171cdfa225656c0046e/5e03e674-eb70-4c02-b12a-fa2b260f1f54-_D__Carrick_Therapeutics_Press_announces_first_patient_on_CT7001_30th_Nov_2017_142.jpg)
![[D] BSGACPGBIPHE Post polypectomy and post colorectal cancer resection surveillance guidelines.pdf](/uploads/r/null/b/3/2/b32916169f7762a553a40633af5f8c4acd6f0fcd93ca9be871145ba39a392a68/7d535a01-622d-41ee-9cb5-2955b1be67db-_D__BSGACPGBIPHE_Post_polypectomy_and_post_colorectal_cancer_resection_surveillance_guidelines_142.jpg)
![[D] British Medical Ultrasound Society guidelines.pdf](/uploads/r/null/1/f/8/1f8c2c4e435190aace18c7b04e6cc60171764254e6964f328fe635d5c9d4d84a/142cb58d-8ac3-479d-813b-36f554d5cc4b-_D__British_Medical_Ultrasound_Society_guidelines_142.jpg)
![[Civ] Reports from Imperial College considered at SAGE meetings Meeting 13, 5th March 2020.pdf](/uploads/r/null/9/0/7/907c42af2864e3ae81282939e005702be9b6ee477bac0bdcbd3c0c4958a34a88/43f0fc8b-3a78-439d-a6ae-0d7e26b13dd3-_Civ__Reports_from_Imperial_College_considered_at_SAGE_meetings_Meeting_13__5th_March_2020_142.jpg)
![[Ciii] Reports from Imperial College considered at SAGE meetings Meeting 12, 3rd March 202.pdf](/uploads/r/null/9/e/1/9e142bd64dbf08ef758cf225d590c65327406c3340c3b2c39fa1ef67b7dd44f3/89230f03-fba9-4c8f-a46e-3f57d0df5898-_Ciii__Reports_from_Imperial_College_considered_at_SAGE_meetings_Meeting_12__3rd_March_202_142.jpg)
![[Cii] Reports from Imperial College considered at SAGE meetings Meeting 10, 25 February 2020.pdf](/uploads/r/null/9/7/8/978bc96a99e35fe0fe65168e9eb3275586993fdf58025b68e3b11effd99ef4db/28a11fd6-eaa7-48e3-9945-c551d1202174-_Cii__Reports_from_Imperial_College_considered_at_SAGE_meetings_Meeting_10__25_February_2020_142.jpg)
![[Cii] EMA Orkambi approval documents Approval for use in patients 6 years and older.pdf](/uploads/r/null/0/e/6/0e6ea321eb24fd572a1dab7b64b3bf165cea74705c8afa1478fd0e62a2a60231/75b65d32-fa41-4f2f-83c1-b48de27c6f8b-_Cii__EMA_Orkambi_approval_documents_Approval_for_use_in_patients_6_years_and_older_142.jpg)
![[Ci] Reports from Imperial College considered at SAGE meetings Meeting 9, 20th February 2020.pdf](/uploads/r/null/d/3/0/d30aad296c6a971c33e9428961f7c18672dcfdd40a64440a62265909840f9261/598f5731-e6cc-47a2-9abd-684d59852931-_Ci__Reports_from_Imperial_College_considered_at_SAGE_meetings_Meeting_9__20th_February_2020_142.jpg)
![[Ci] EMA Orkambi approval documents Approval for use in patients 12 years and older.pdf](/uploads/r/null/c/5/8/c5899e08d80d55921956995ba6877c3eb46975d987de0c6d571fb9cde8bff91b/52f73e0d-7dc5-4b7b-9f47-a8f415418a42-_Ci__EMA_Orkambi_approval_documents_Approval_for_use_in_patients_12_years_and_older_142.jpg)
![[C] ZOT - Fuel Cell Manufacturing](/uploads/r/null/d/5/5/d55b8676f3b8f35c0a6a59c3fe37f7bad91914e2694a2b093fa3b76dc70aebbf/9d9c5ce2-f101-439c-bee8-a426b4b127cf-_C__zot-co-uk-newsitem-php-2021-02-05-17_37_47_142.jpg)
![[C] Written evidence from the Royal Statistical Society (DTA 42) to the Public Administration and Constitutional Affairs Committee Data Transparency and Accountability Covid 19 (November 2020.pdf](/uploads/r/null/d/f/f/dff4418cc72ed4bd02829deec3aea45647e366ee6b25f5f46e0799c730618fbc/4de5ba12-a7c7-4495-ae0f-190d05c9b156-_C__Written_evidence_from_the_Royal_Statistical_Society__DTA_42__to_the_Public_Administration_and_Constitutional_Affairs_Committee_Data_Transparency_and_Accountability_Covid_19__November_2020_142.jpg)